Finally, the relative abundance of CD44+CD62L− T effector cells in tumor-draining lymph nodes (tdLNs) was higher in DCP-IL-12/FLT3L-treated mice (Extended Data Fig. 5e), suggesting activation of a systemic T cell response. Here, CD44 is linked to neoplasm.